A Decade of Sleeve Gastrectomy: Analysis of Short and Long-term Outcome of 562 Patients
A Decade of Sleeve Gastrectomy: Analysis of Short and Long-term Outcome of 562 Patients
Obesity is a chronic disease and its treatment requires close follow-up to accurately assess
 the efficacy and durability of any treatment strategy. It is widely accepted that bariatric
 surgery patients require lifetime follow-up to assess for weight loss, co-morbidity changes,
 and nutritional deficiencies.

 The study objective was to ascertain efficacy of weight loss and complication rates in 562
 consecutive cases of laparoscopic sleeve gastrectomy (LSG) in a single surgeon practice.
Obesity is a major healthcare problem reaching epidemic proportion and affecting people of
 all age (1). The only treatment that proven effective option for a significant substantial
 long-term weight loss and that cures or durably improves comorbidities is still bariatric
 surgery (2, 3). Because obesity is a chronic disease, it is widely accepted that to
 accurately assess the efficacy and durability of any type of bariatric surgery requires
 lifetime follow-up to assess for weight loss, co-morbidity changes, and nutritional
 deficiencies.

 Despite initially performed as a first part of the staged procedures, the laparoscopic sleeve
 gastrectomy (LSG) has since introduced as a stand-alone bariatric operation associated with
 good, short and mid-term weight loss and satisfactory complication rates when conducted in
 experienced hands. Although simplicity and the overall efficacy of the procedure supported by
 meta-analysis and systematic review (4, 5), there are still limited long-term outcome data
 (6). Due to publication bias or multiple controversies regarding the technique of LSG, some
 of the available data may have underreported which has also been resulted in questioning the
 long-term weight loss efficacy of the procedure.

 Although addressed by a recent consensus document,12 there are multiple controversies
 regarding the technique of LSG, and this may in part be what has led to the variable
 published results.

 The study objective was to assess the long-term (≥ 5 years) as well as short (1 to ≤ 3 years)
 and mid-term (> 3 to < 5 years) results in regard to the BMI change, resolution of
 co-morbidities and complications in 562 consecutive morbidly obese patients undergoing LSG as
 a primary procedure.
Inclusion Criteria:

 -  underwent LSG for morbid obesity and related morbidities as a primary procedure

 Exclusion Criteria:

 -  previous history of obesity surgery